These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16230627)

  • 1. Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies.
    Rodriguez-Martin T; Garcia-Blanco MA; Mansfield SG; Grover AC; Hutton M; Yu Q; Zhou J; Anderton BH; Gallo JM
    Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15659-64. PubMed ID: 16230627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing.
    Rodriguez-Martin T; Anthony K; Garcia-Blanco MA; Mansfield SG; Anderton BH; Gallo JM
    Hum Mol Genet; 2009 Sep; 18(17):3266-73. PubMed ID: 19498037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.
    Wang Y; Wang J; Gao L; Stamm S; Andreadis A
    Gene; 2011 Oct; 485(2):130-8. PubMed ID: 21723381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of alternative splicing of tau exon 10.
    Qian W; Liu F
    Neurosci Bull; 2014 Apr; 30(2):367-77. PubMed ID: 24627328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10.
    Yu Q; Guo J; Zhou J
    J Neurochem; 2004 Jul; 90(1):164-72. PubMed ID: 15198676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17.
    Kalbfuss B; Mabon SA; Misteli T
    J Biol Chem; 2001 Nov; 276(46):42986-93. PubMed ID: 11560926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous nuclear ribonucleoprotein E3 modestly activates splicing of tau exon 10 via its proximal downstream intron, a hotspot for frontotemporal dementia mutations.
    Wang Y; Gao L; Tse SW; Andreadis A
    Gene; 2010 Feb; 451(1-2):23-31. PubMed ID: 19914360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.
    Gu J; Chen F; Iqbal K; Gong CX; Wang X; Liu F
    J Biol Chem; 2017 Jun; 292(25):10600-10612. PubMed ID: 28487370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17.
    Jiang Z; Cote J; Kwon JM; Goate AM; Wu JY
    Mol Cell Biol; 2000 Jun; 20(11):4036-48. PubMed ID: 10805746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.
    Zhou J; Yu Q; Zou T
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S10. PubMed ID: 19090983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural determinants for alternative splicing regulation of the MAPT pre-mRNA.
    Lisowiec J; Magner D; Kierzek E; Lenartowicz E; Kierzek R
    RNA Biol; 2015; 12(3):330-42. PubMed ID: 25826665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau alternative splicing in familial and sporadic tauopathies.
    Niblock M; Gallo JM
    Biochem Soc Trans; 2012 Aug; 40(4):677-80. PubMed ID: 22817715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-splicing correction of tau isoform imbalance in a mouse model of tau mis-splicing.
    Avale ME; Rodríguez-Martín T; Gallo JM
    Hum Mol Genet; 2013 Jul; 22(13):2603-11. PubMed ID: 23459933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10.
    Hasegawa M; Smith MJ; Iijima M; Tabira T; Goedert M
    FEBS Lett; 1999 Jan; 443(2):93-6. PubMed ID: 9989582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.
    Ray P; Kar A; Fushimi K; Havlioglu N; Chen X; Wu JY
    J Mol Neurosci; 2011 Nov; 45(3):453-66. PubMed ID: 21881826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5' exon replacement and repair by spliceosome-mediated RNA trans-splicing.
    Mansfield SG; Clark RH; Puttaraju M; Kole J; Cohn JA; Mitchell LG; Garcia-Blanco MA
    RNA; 2003 Oct; 9(10):1290-7. PubMed ID: 13130143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA.
    Kondo S; Yamamoto N; Murakami T; Okumura M; Mayeda A; Imaizumi K
    Genes Cells; 2004 Feb; 9(2):121-30. PubMed ID: 15009090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model.
    Dawson HN; Cantillana V; Chen L; Vitek MP
    J Neurosci; 2007 Aug; 27(34):9155-68. PubMed ID: 17715352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegenerative disorder FTDP-17-related tau intron 10 +16C → T mutation increases tau exon 10 splicing and causes tauopathy in transgenic mice.
    Umeda T; Yamashita T; Kimura T; Ohnishi K; Takuma H; Ozeki T; Takashima A; Tomiyama T; Mori H
    Am J Pathol; 2013 Jul; 183(1):211-25. PubMed ID: 23680655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. tau Exon 10 expression involves a bipartite intron 10 regulatory sequence and weak 5' and 3' splice sites.
    D'Souza I; Schellenberg GD
    J Biol Chem; 2002 Jul; 277(29):26587-99. PubMed ID: 12000767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.